A novel use of liraglutide: induction of partial remission in ulcerative colitis and ankylosing spondylitis
Treatment usually begins with a lower dose to help your body adjust comfortably
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomized, 52-week, phase III, double-blind, parallel-treatment trial
What Self-Pay Actually Costs in 2026 With roughly two-thirds of employers not covering GLP-1s for weight loss, self-pay remains the reality for most patients
In addition to its effects on metabolic regulation, GLP-1, when synthesized within the brain, exhibits neuroprotective properties
How PlexusDx Supports a More Personalized Approach PlexusDx partners with licensed 503A compounding pharmacies to provide customizable semaglutide and tirzepatide at costs lower than most branded alternatives